Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Voll Degradable Shoulder Spacer FIH Study

NCT: NCT07208448 · RECRUITING

NCT IDNCT07208448
StatusRECRUITING
Start Date2025-12-09
Completion2027-12-31
SponsorVoll Medical Technologies Ltd. (INDUSTRY)
First posted
Last updated

Brief Summary

The Voll Degradable Shoulder Spacer First-in-Human study aims to evaluate the initial safety, effectiveness, and clinical outcomes of a degradable shoulder spacer in over 50 years old patients with symptomatic massive rotator cuff tears (MRCT).

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑